ELRIG.de Forum 2018 - Darmstadt
New Innovative Trends in Early Drug Discovery and Sample Management
|
08:00 |
08:30 |
Registration |
|
|
|
08:30 |
08:35 |
Welcome by the Chairman of ELRIG.de e.V. |
Tobias May |
Elrig.de e.V. |
|
08:35 |
09:00 |
Innovations in Antibiotic Related Drug Discovery |
Andreas Vilcinskas |
Fraunhofer, Gießen, D |
|
09:00 |
09:25 |
Semi-automated Reception and Processing of Patient Samples for the Production of an individualized Vaccine |
Christine Hawner |
BioNtech, Mainz, D |
|
09:25 |
09:50 |
Accurate biological sample tracking – benefits, challenges and considerations |
Tim Stroud |
Titian Software, UK |
|
09:50 |
10:15 |
Lab 4.0 – Future trends in life sciences research and drug development |
Martina Hampel |
Fraunhofer IPA, Stuttgart, D |
|
10:15 |
10:45 |
Coffee break & Poster session |
|
|
|
10:45 |
11:10 |
Integrated Data and Workflow Management in High-throughput Cell Line Screening |
Christoph Freiberg |
GeneData, Basel, CH |
|
11:10 |
11:35 |
High-throughput screening using multicellular spheroids to reveal and exploit tumor-specific vulnerabilities |
Wojciech Senkowski; |
Uppsala University, S |
|
11:35 |
12:00 |
Creating functional barriers in vitro. Lessons from lung and gut |
Kristina Nehlsen |
InSCREENeX, Braunschweig, D |
|
12:00 |
12:25 |
Human induced pluripotent stem cell-derived cardiomyocytes - Case studies for the application in early drug development |
Ralf Kettenhofen |
Ncardia, Köln, D |
|
12:25 |
14:00 |
Lunch Break & Poster Session |
|
|
|
14:00 |
14:25 |
Target- based & phenotypic screening approaches |
Stephen Hess |
Evotec, Hamburg, D |
|
14:25 |
14:50 |
Hit identification strategy at Merck: DELT |
Ingo Kober |
Merck KGaA, Darmstadt, D |
|
14:50 |
15:15 |
The Yin and Yang of CRISPR Screening: A Dual Approach to Revolutionize Drug Discovery |
Jochen Hartner |
Horizon Discovery Ltd, Cambridge, UK |
|
15:15 |
15:45 |
Coffee break & Poster session |
|
|
|
15:45 |
16:10 |
Are you on target? Probing target engagement |
Susanne Müller-Knapp |
SGC Univ. Oxford, UK |
|
16:10 |
16:35 |
Differentiated human iPS cells in disease modeling and drug screening initiatives |
Sabine Lange |
Cellular Dynamics, Madison, USA |
|
16:35 |
17:00 |
Hit Identification strategy at Merck: High Throughput MALDI-TOF |
Martin Hoffmann |
Merck, Darmstadt, D |
|
17:00 |
|
End of Forum 2018 |
|
|
